Volume : 08, Issue : 12, December – 2021
Title:
28.SIMULTANEOUS RP-HPLC METHOD FOR DETERMINATION OF BETAMETHASONE DIPROPIONATE AND TOLNAFTATE IN COMBINED SEMISOLID FORMULATION
Authors :
Banoth Ashok*, V. Jagannath Patro
Abstract :
A new RP-HPLC method was developed for selective and simultaneous determination of betamethasone dipropionate and tolnaftate in combined semisolid formulation containing other components. Further, the proposed method was validated for linearity, precision (system precision, method precision, intermediate or inter-day precision), accuracy, stability in analytical solution, robustness or system suitability and ruggedness. The developed method exhibited the best results in terms of the aforesaid validation parameters. The other components and additives did not interfere in their determinations. The method was found to be selective, simple, economical, accurate, reproducible, rapid and reliable for routine estimation purpose of these drugs in combined semisolid formulations.
Key-words: Betamethasone dipropionate, tolnaftate, RP-HPLC, semisolid formulation.
Cite This Article:
Please cite this article in press Banoth Ashok et al, Simultaneous RP-HPLC Method For Determination Of Betamethasone Dipropionate And Tolnaftate In Combined Semisolid Formulation., Indo Am. J. P. Sci, 2021; 08(12).
Number of Downloads : 10
References:
1. ChandraNathSaha and Sanjib Bhattacharya, A validated simultaneous Rp-HPLC method, International Journal of c Chem Tech Research, July 2009,vol1, no.3, p 671-674.
2. Ermer J., Miller J. H. M. Method Validation in Pharmaceutical Analysis: A Guide to Best Practice. Wiley-VCH-Verlag-GmbH & Co., Weinheim, 2005
3. C. Sweetman. Martindale the complete drug reference, 29th edition, Pharmaceutical Press, London, 2005, p. 416.3 and 1093.3.
4. Merck index an encyclopedia of chemicals drugs and biologicals, 14th edition, White House Station NJ, USA, 2006, p. 1438 and 9519.
5. Sethi P.D HPLC Quantitative analysis of drugs in pharmaceutical formulations, 1st edition, CBS publishers and distributors, New Delhi: 2007, Vol II P.121, 469, 473, 475, 477, 479, 481,483.
6. Unites States Pharmacopoeia 31 NF26, Asian edition, 2008, Vol-III, p. 3211-3212 and 3433-3434.
7. Sethi P.D HPTLC Quantitative analysis of pharmaceutical formulations, 1st edition, CBS publishers and distributors, New Delhi: 1996 p.410-413.
8. Shou M, Galinada WA, Wei YC, Tang Q, Markovich RJ, Rustum AM. Development and validation of a stability-indicating HPLC method for simultaneous determination of salicylic acid, betamethasone dipropionate, and their related compounds in Diprosalic Lotion.J Pharm Biomed Anal. 2009Oct15;50(3):356-61.Epub 2009 May 23. Pub Med PMID:19545962.
9. A validated simultaneous RP-HPLC method for determination of Betamethasone dipropionate and tolnaftate in combined semisolid formulation.Chandranath Saha and sanjib bhattacharya.
10. Indian pharmacopoeia, Indian pharmacopoeia commission Ghaziabad: 2010, Vol-III, P-2089 and 2238-2240. 1998;94:557–72.
11. Barnes PJ. Therapeutic strategies for allergic diseases. Nature. 1999;402(Suppl 6760):B31–8.
12. Haynes RC., Jr .Thyroid and antithyroid drug. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press; 1990. p. 1361–83.
13. Genotoxic and Carcinogenic Impurities in Drug Substances and Products: Recommended Approaches. FDA Center for Drug Evaluation and Research. Guidance for Industry (Draft) 2008 Dec 03;
14. Roy J. Pharmaceutical Impurities-A Mini-Review. AAPS PharmSciTech. 2002;3(2):E6.
15. Ueda CT, Shah VP, Derdzinski K, Ewing G, Flynn G, Maibach H, et al. Topical and Transdermal Drug Product-Stimuli to the revision process. Pharmacopeial Forum. 2009;35: p 750–64.
61.